STANDARD BIOTOOLS INC. — Income Charts
63 quarters of history · ending 2025-12-31 · SEC EDGAR
Revenue
$24M
Cost of Revenue
$12M
Gross Profit
$11M
R&D
$8M
SG&A
$25M
D&A↑+62.5% +$500K
$1M
Operating Income↓-23.4% -$6M
$-33M
EBITDA↑+62.5% +$500K
$1M
Interest Expense↓-7.7% -$92K
$1M
Pretax Income↓-50.9% -$11M
$-33M
Tax Provision↓-1130.5% -$1M
$-1M
Net Income↓-28.8% -$8M
$-35M
Gross Margin
47.8%
Operating Margin↓-47.6pts
-168.5%
Net Margin↓-55.4pts
-177.4%